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DiffusionSterols, as cholesterol in mammalian cells and ergosterol in fungi, are indispensable molecules for proper func-
tioning and nanoscale organization of the plasmamembrane. Synthesis, uptake and efﬂux of cholesterol are reg-
ulated by a variety of protein–lipid and protein–protein interactions. Similarly, membrane lipids and their
physico-chemical properties directly affect cholesterol partitioning and thereby contribute to the highly hetero-
geneous intracellular cholesterol distribution. Movement of cholesterol in cells is mediated by vesicle trafﬁcking
along the endocytic and secretory pathways as well as by non-vesicular sterol exchange between organelles. In
this article, wewill review recent progress in elucidating sterol–lipid and sterol–protein interactions contributing
to proper sterol transport in living cells. We outline recent biophysical models of cholesterol distribution and dy-
namics inmembranes and explain how suchmodels are related to sterolﬂux between organelles. An overview of
various sterol-transfer proteins is given, and the physico-chemical principles of their function in non-vesicular
sterol transport are explained. We also discuss selected experimental approaches for characterization of
sterol–protein interactions and for monitoring intracellular sterol transport. Finally, we review recent work on
the molecular mechanisms underlying lipoprotein-mediated cholesterol import into mammalian cells and de-
scribe the process of cellular cholesterol efﬂux. Overall, we emphasize how speciﬁc protein–lipid and protein–
protein interactions help overcoming the extremely low water solubility of cholesterol, thereby controlling
intracellular cholesterol movement. This article is part of a Special Issue entitled: Lipid–protein interactions.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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Cholesterol attracts continuous interest of physicians, cell biol-
ogists, biochemists and biophysicists due to its uttermost impor-
tance in human pathobiology, its central role in regulating
cellular functions, its complex metabolism and its impact on
membrane structure and dynamics. The last three decades have
witnessed a tremendous increase in our understanding of choles-
terol transport between tissues and control of cholesterol homeo-
stasis at an organism level [1–3]. Similarly, a lot of effort has
been put into characterizing the membrane organization of
cholesterol as well as in determining its effect on membrane
proteins. In contrast to that progress, the dynamical aspects,
energetics, protein-dependence and overall regulation of intracel-
lular cholesterol transport are only beginning to become resolved.
Cholesterol in mammalian cells and ergosterol in fungi play a
central role in regulating the permeability barrier and overall
structural organization of the plasma membrane (PM) which is
why both sterols are highly enriched in that membrane compared
to most intracellular organelles. Intermediate cholesterol concen-
trations are found in early endosomes and the trans-Golgi net-
work (TGN), while mitochondria and the endoplasmic reticulum
(ER) harbor only low amounts of cholesterol (i.e. the amount of
cholesterol in the ER is below 5% of total relative to the PM
with about 60–70% of total). A central question is how the low
abundance of cholesterol in the ER is maintained despite the
fact that this is the site of cholesterol synthesis and esteriﬁcation.
The ER contains several proteins with essential function in
cholesterol metabolism. For example, hydroxymethylglutaryl-
coenzyme A (HMG-CoA) reductase catalyzes formation of
mevalonate in the cytoplasm, which is the rate-limiting step in
cholesterol synthesis. Its activity is regulated in a fascinating
manner via a protein complex with sterol response element bind-
ing protein 2 (SREBP2), its escort proteins Scap and Insig, which
all localize to the ER in cells with normal cholesterol levels. Cho-
lesterol homeostasis is regulated in a convergent feedback loop
involving these proteins, and sudden changes in ER cholesterol
trigger metabolic responses [4–7]. If cholesterol levels in the ER
drop, Insig dissociates from Scap/SREBP2 and gets degraded by
the proteasome [8]. The Scap/SREBP2 complex is transported in
COPII vesicles to the Golgi following normal anterograde mem-
brane trafﬁc, and in the Golgi, two serine proteases cleave the
N-terminal domain of SREBP2. This domain travels to the nucleus,
where it acts as transcription factor promoting the expression of
several genes involved in cholesterol synthesis, uptake and trans-
port [8]. Scap binds cholesterol directly, likely via its sterol
sensing domain, while expression of Insig (at least Insig-1) is
controlled by the SREBP2 transcription factor. Once normal cho-
lesterol levels are restored and sufﬁcient new Insig is synthesized,
the Insig/Scap/SREBP2 complex reforms in the ER, and acquisition
of new cholesterol by the cell (via synthesis or uptake of low
density lipoprotein (LDL)) ceases. Several excellent reviews have
been published in the last few years about these processes
[8–11], and we will not discuss the details further here. Instead,
we continue with a brief overview of experimental approaches
for analysis of cholesterol transport (Sections 2.1 and 2.2). This
is especially important due to the fact that our limited knowledge
about intracellular cholesterol trafﬁcking is largely a consequence
of technical hurdles. We will also brieﬂy discuss several experi-
mental approaches for studying protein–sterol interactions and
protein-mediated inter-membrane sterol transport (Section 2.3.).
Kinetic and thermodynamic aspects of cholesterol–lipid interac-
tion and inter-membrane cholesterol transfer are explained in
Section 3. A survey of speciﬁc protein–lipid and protein–protein
interactions during intracellular cholesterol movement, uptake
and efﬂux is provided in Section 4.2. Tools for studying sterol trafﬁcking and sterol–protein
interactions
2.1. Quantitative approaches for analysis of intracellular transport
processes
Intracellular transport studies in general demand speciﬁc and robust
labeling of the transported entity with minimal alteration of the inves-
tigated transport process by the labeling strategy. This aspect is particu-
larly critical for elucidation of lipid transport processes, inwhich tagging
with a reportermoiety can signiﬁcantly affect the properties of the stud-
ied molecule. The experimenter must also decide whether steady state
or dynamic information will be gathered in a particular investigation.
For example, the polyene macrolide ﬁlipin will report about the steady
state distribution of cholesterol or other sterols bearing a free 3-hydroxy
group, while no kinetic information can be inferred by that approach
[12]. Also, ﬁlipin staining would not report about the origin of a partic-
ular sterol pool. Similar arguments apply to studies using sterol-binding
proteins, as ﬂuorescence tagged perifringolysin O (PFO) [12]. Dynamic
information about cellular transport can be inferred in one of three
ways; I) one deﬂects the cellular system from its steady state and fol-
lows the system response as a function of time. This approach is used
in pulse-chase experiments of isotope- or ﬂuorescence-labeled mole-
cules as well as in ﬂuorescence recovery after photobleaching (FRAP)
of suitable ﬂuorescent sterols [13,14]. Pulse-chase studies are alsowide-
ly used for deciphering lipoprotein-mediated sterol import into cells,
and such studies can be easily coupled tometabolic experiments, for ex-
ample of cholesteryl ester (CE) hydrolysis and reesteriﬁcation of choles-
terol [15] as well as of cholesterol synthesis and transport [16]. II)
transport can be studied by creating a permanent sink as a consequence
of constantly removing some tagged molecules from the system, as is
done in ﬂuorescence loss in photobleaching (FLIP) [17]. In contrast, to
theﬁrst strategy, the system is permanently disturbed and nonewglob-
al steady state can be re-established in FLIP studies. III) cells become
steady-state labeled with the tagged molecule of interest, for example
cholesterol with an attached BODIPY group in the side chain (BChol or
TopFluor-cholesterol as trade name) and stochastic ﬂuctuations around
the steady state value are monitored as function of time [18,19]. This
approach is only applicable with bright and photostable ﬂuorescent
reporter groups allowing for either long term tracking of sterol-rich
vesicles or for unbiased analysis of ﬂuorescence ﬂuctuations due to
molecular transport [18]. According to the ﬂuctuation–dissipation
theorem, comparable transport rates can be inferred from the response
of the system to a perturbation (i.e., strategies I) and II), above) as well
as from long-term analysis of ﬂuctuations around a mean value
(i.e., strategy III), above) [20]. In the latter case, transport coefﬁcients,
as diffusion constants, are derived from time correlation functions, as
in ﬂuorescence correlation spectroscopy (FCS) and its imaging variants
[21,22]. Alternatively, statistical ensembles are generated by single par-
ticle tracking (SPT) followed bymoment analysis of the experimentally
determined probability density function (PDF). For example, in SPT the
secondmoment of the step length distribution for recorded trajectories
gives the mean square displacement from which diffusion constants or
ﬂow speed can be extracted using adequate transport models [23–26].
FRAP and SPT have been shown to provide comparable information in
case of membrane diffusion [26], while similar transport coefﬁcients
were found for intracellular vesicles using either ﬂuorescence ﬂuctua-
tion analysis or SPT [27].
2.2. Radioactive and ﬂuorescent probes for studying sterol transport and
metabolism
Cholesterol synthesis can be investigated using 3H-acetate or other
isotope-labeled precursors [16,28]. Cholesterol esteriﬁcation is often
determined by feeding cells 3H-cholesterol or 3H-oleate and analyzing
the amount of formed radioactive CEs [29,30]. Isotope-labeled
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dependence and kinetics of sterol clearance fromcells [31]. Cyclodextrin
is often used in such studies, either to introduce the labeled sterols se-
lectively into the plasma membrane or to allow for sterol extraction
from cells in efﬂux experiments [31–33]. Cyclodextrin is similarly used
in studies involving ﬂuorescent cholesterol analogs, and cholesterol-
containing cyclodextrin is useful for exchanging a labeled sterol pool
or for acute cholesterol loading of cells [13,34,35]. Uptake of sterol-
containing lipoproteins can be followed by appropriate ﬂuorescence-
tagging of the apoprotein or by scintillation chromatography based on
125I-tagged apoproteins [36,37]. Hydrolysis of isotope-labeled CEs
will, combined with assessment of apoprotein degradation using
trichloracetic acid precipitation, report about intracellular degradation
of the lipoprotein [36,38]. Double-isotope studies using 3H- or 13C-
sterols are also possible, either to assess re-esteriﬁcation of LDL-
liberated cholesterol or to determine the extent of esteriﬁcation of
different cholesterol pools [39]. Another tool to generate strong concen-
tration gradients is to use hydrophobic amines, such as U18666A, and
steroid hormones, as progesterone, to trap cholesterol in late
endosomes and lysosomes (LE/LYSs) [15,40]. Washout of these com-
pounds allows for kinetic and metabolic analysis of the intracellular
fate of cholesterol released from these compartments [32,39]. Use of
ﬂuorescent analogs of cholesterol combined with suitable imaging
technology provides an alternative strategy for gaining insight into ste-
rol transport pathways and dynamics in cells. Fluorescent cholesterol
analogs bear either a covalently linked ﬂuorescent dye of suitable
color and brightness or are intrinsically ﬂuorescent due to a small con-
jugated system in the steroid backbone of the sterols. Most cholesterol
analogs with extrinsic reporter group fail to mimic cholesterol ade-
quately inmodelmembranes and in cellular studies [12,41]. A somehow
reasonable exception is TopFluor-cholesterol which has been success-
fully used in cells and model organisms, even though it is miss-
targeted in cells with high fat content [35,42]. However, BChol or
TopFluor-cholesterol fails to order fatty acyl chains in model mem-
branes, an important property of cholesterol to bemimicked by suitable
cholesterol analogs [43,44]. Ultraviolet (UV)-sensitive wide ﬁeld (UV-
WF) and multiphoton microscopy of intrinsically ﬂuorescent sterols,
such as cholestatrienol (CTL) and dehydroergosterol (DHE) as close
analogs of cholesterol and ergosterol has provided new insight into
cellular sterol trafﬁcking [13,17,34,45,46]. Their poor ﬂuorescence prop-
erties justify the quest for development of further sterol probes. Impor-
tantly, metabolic studies on intracellular esteriﬁcation are also possible
with ﬂuorescent sterols [34,35]. A different tagging strategy is to
synthesize alkyne-labeled cholesterol or oxysterols, which after cellular
uptake become chemically linked to a ﬂuorescent dye, as BODIPY [47,
48]. A disadvantage here is the need for ﬁxation of cells making live-
cell imaging studies impossible. For further details, the reader is referred
to recent technical reviews [12,49–51].
2.3. Biophysical characterization of sterol–protein interactions
Non-vesicular transport of cholesterol and ergosterol in mammalian
and yeast cells, respectively depends on cytosolic lipid transfer proteins
(LTPs). Non-speciﬁc LTPs, as cytosolic sterol carrier protein 2 (SCP2) and
fatty acid bindingproteins (FABPs) transfer sterols and a variety of other
lipids between model and cell membranes and bind their ligands with
micromolar afﬁnity [52,53]. Speciﬁc LTPs bind and transfer only one or
two types of lipids, sometimes in exchange against each other and
often show afﬁnities in the low nanomolar range [54,55]. Examples of
the latter category are members of the family of oxysterol binding pro-
teins (OSBPs), steroidogenic acute regulatory (StAR) proteins and
elicitins — plant defensins to which the Niemann Pick C2 protein
(NPC2) shows high structural similarity [56–59]. All LTPs were shown
to bind their respective ligand and to transfer it between liposomes. In
case of sterols, typical binding assays consist ofmaking an often aqueous
solution of either radiolabeled or ﬂuorescent sterol and adding theprotein in the absence or presence of excess unlabeled sterol [54]. In
such competition assays, apparent dissociation constants (KD) for cho-
lesterol or other sterols, as oxysterols, to LTPs have been determined.
Sterol binding to LTPs can be also measured by NMR spectroscopy or
by H/D exchange followed by mass spectrometry detection [60,61].
When using ﬂuorescent analogs, intrinsically ﬂuorescent sterols as
DHE or CTL are clearly preferable compared to tagged cholesterol, as
NBD-, Dansyl or TopFluor-cholesterol, since binding equilibria are
strongly affected by the presence of the ﬂuorophore in the latter analogs
[62]. For example, side-chain tagged NBD-cholesterol binds to Niemann
Pick C1 protein (NPC1) but not to NPC2 [62]. This is likely a direct con-
sequence of the opposite orientation of the sterol in the respective bind-
ing pocket; while in NPC1, sterols bind with their 3′-hydroxy group
buried inside the binding pocket [63], in NPC2, the sterol side chain
points into the binding region (see Section 4.3., below) [64]. According-
ly, the ﬂuorophore in NBD-cholesterol will interfere with binding to
NPC2 but not to NPC1. On the other hand, DHE and/or CTL have been
used to demonstrate sterol binding of NPC2 [65,66], FABPs [52], SCP2
[67], NPC1 [62], yeast homologs of OSBPs [68,69], StAR proteins [14]
and elicitins [70]. Photo-crosslinking of a suitable cholesterol analog to
the protein of interest can be also used as evidence for sterol-binding ca-
pacity [49,62,71]. This strategy can be combined with click-chemistry
via a side-chain alkyne group to generate a bifunctional cholesterol
probe [72]. Combined with stable-isotope labeling by amino acids in
cell culture (SILAC) mass spectrometry, such a bifunctional cholesterol
probe has been employed to identify over 250 sterol-interacting
proteins [72]. Beside many known sterol-binding proteins, several
new candidates were identiﬁed, which were formerly known only
from their function in sugar and glycerolipid metabolism. To determine
speciﬁc sterol binding to a reconstituted membrane protein, immuno-
afﬁnity tagging to sepharose beads has been used followed by adding
radioactive cholesterol in a buffer solution, centrifugation of the bead-
protein/ligand complex and extraction of bound sterol with organic
solvent [73]. Estimation of comparable KD values is often impeded by
the low monomeric solubility of cholesterol and its analogs, as DHE,
which is far below 100 nM [74,75]. Accordingly, cholesterol or ﬂuores-
cent sterols will form crystals or micelles, which, however, are not
taken explicitly into account in most published assays reporting KD
values. Also, different solubility of cholesterol and its oxidized metabo-
lites can bias the measured afﬁnity values to LTPs [54,66]. Such
problems can be circumvented by inserting the sterol ligand into a
supported bilayer followed by detection of protein binding using sur-
face plasmon resonance [68]. Alternatively, the critical concentration
of sterol aggregate formation is explicitly taken into account in the
estimation of binding equilibria [76].
Binding stoichiometries of sterols to LTPs have been estimated by
ﬂuorescence approaches, calorimetry or circular dichroism [52,53,76].
Again, cholesterol analogs with extrinsic ﬂuorophore, as NBD-
cholesterol gave deviating binding stoichiometry (2:1) compared to na-
tive cholesterol (1:1) to the StAR protein, themitochondrial cholesterol
importer [76–78]. Chemical modiﬁcation of the sterol structure can also
have a large impact on inter-membrane sterol transfer catalyzed by
LTPs. For example, the BODIPY-group in TopFluor-cholesterol was
found to block interbilayer transport of that analog by StARD4, a cyto-
plasmic sterol transport protein in mammalian cells (Fred Maxﬁeld,
Cornell Medical College; personal communication). In contrast,
StARD4 transferred DHE with similar efﬁciency as cholesterol between
model membranes and between the PM and the endocytic recycling
compartment (ERC) in living CHO cells [14]. Inter-bilayer exchange of
DHE and CTL has become a standard method for determining transfer
activity of a variety of LTPs. Two readouts of these sterols can be used
for that purpose: (1) relief of Förster resonance energy transfer from
DHE or CTL to Dansyl-tagged phosphatidyl ethanolamine (Dansyl-PE).
This assay has been originally developed to assess DHE's ﬂip-ﬂop in
model membranes by stopped ﬂow-based monitoring of cyclodxtrin-
mediated sterol extraction [79]. Two kinetic phases were found in
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transbilayer migration. Later, this assay was used to monitor DHE and
CTL transfer between membranes by a variety of LTPs including NPC2
[80], StARD4 [14], the yeast OSBP homologue Osh 4 [69], OSBP
[81] and OSBP related protein 9 (ORP9) [82]. (2) DHE shows a
concentration-dependent decline in ﬂuorescence polarization or anisot-
ropy which has been used to predict sterol transbilayer dimers at low
sterol concentration [75,83]. This property was used ﬁrst by Schroeder
and colleagues to quantify sterol transport by SCP2 and FABPs between
model and cellular membranes [84,85]. Similarly, Slotte and colleagues
has used anisotropy as readout for equilibrium partitioning of CTL
between membranes [86]. Both assays do not depend on separation
of donor and acceptor vesicles, a problem which otherwise has been
tackled, when using radioactive or unlabeled cholesterol [87,88].
3. Modes and models of intracellular cholesterol transport
3.1. Is the heterogeneous distribution of cholesterol in cells based on
equilibrium thermodynamics?
More than 30 years ago, Silbert and colleagues found that isotope-
labeled cholesterol resides preferentially in puriﬁed PM fractions com-
pared to membrane fractions made of ER or mitochondria in LM cells
[89]. The same tendency (but not the same numbers) was found in
lipid extracts made from these membrane fractions. Given the highly
different phospho- and sphingolipid composition of PM versus ER and
mitochondria, the authors speculated that the properties of the host
lipid species in a particular organelle determine the differentmembrane
afﬁnities of cholesterol (and related sterols) and consequently the het-
erogeneous intracellular cholesterol distribution [89]. This is plausible,
given that cholesterol clearly shows preferred interaction with mem-
branes consisting of saturated sphingomyelin (SM) and phosphatidyl-
choline (PC), as found in the PM compared to membranes made of
unsaturated PC and other lipids, as found in the ER [90,91]. Indeed, the
half-time of passive cholesterol transfer between liposomes was found
to decrease in the order dipalmitoyl-PC (DPPC; 4.7 h), dimyristoyl-PC
(DMPC; 3.9 h), dioleoyl-PC (DOPC; 2.6 h), and soy-bean-PC (1.8 h)
[92]. Similarly, Mitropoulos and co-workers found a strong correlation
between net cholesterol transfer between liposomes and ER
membranes puriﬁed from rat liver and the activity of ACAT in thesemi-
crosomes [91]. Thus, the higher themeasured partitioning of cholesterol
into microsomes was, the larger the activity of ACAT in these
membranes. The activation energy for cholesterol transfer from
liposomes containing bovine brain SM was about 45% higher than that
from liposomes made of egg yolk PC [91]. The transfer kinetics was
ﬁrst order with a half-time of ~28 h versus ~3 h at comparable
liposome/microsome ratios for SM- and PC-containing membranes, re-
spectively. Given, that bovine brain SM contains much more saturated
fatty acyl species than egg yolk PC these observations could be a conse-
quence of the more saturated acyl chain species in membranes made of
SM than thosemade of PC. Alternatively, preferred interaction between
cholesterol and SM compared to PC even for similar acyl chain order
could explain the observations by Mitropoulos and colleagues [91].
Partition experiments have indeed shown that cholesterol has
the highest afﬁnity for liposomes made of SM followed by those
made from phosphatidylserine (PS), PC and ﬁnally phosphatidyletha-
nolamine (PE) [90]. Similar results were found using CTL by Slotte and
colleagues using a ﬂuorescence assay based on CTL [93]. These authors
showed additionally that increased membrane order as assessed by
diphenylhexatriene ﬂuorescence in SM containing membranes is not
the primary cause of higher sterol partitioning into SM compared to
PC bilayers [93]. Thus, energetically favorable interfacial properties of
SM compared to PC might stabilize cholesterol in sphingolipid contain-
ing bilayers. Structural differences in the ceramide compared to
the glycerol backbone must account for such properties, as the
phosphorylcholine head group of PC and SM is the same. For example,hydrogen bonding between the 3′-hydroxy group of cholesterol and
the NH-group of the ceramide part of SM could stabilize such interac-
tions. Others, however, could not ﬁnd evidence for a speciﬁc interaction
of cholesterol with SM [94]. Independent of the molecular details, the
observed partition differences of cholesterol for varying head group
and acyl chain composition are fully in accordance with equilibrium
thermodynamics. Let's consider a two-membrane system; membrane
A and membrane Bwith differing phospholipid composition (for exam-
ple A contains saturated PC and B contains unsaturated PC) and choles-
terol as solute within such membranes. Cholesterol's mole fraction in
both membranes reads
xAChol ¼
nAChol
nAPhl þ nAChol
and xBChol ¼
nBChol
nBPhl þ nBChol
: ð1a; bÞ
Here, nCholi and nPhli with i= A, B correspond to the number of choles-
terol and phospholipid molecules in the respective membrane A and B.
Let's assume that cholesterol transfer between both membranes takes
place via the aqueous solution, we can write the scheme
A ⇄
k1
k−1
water ⇄
k2
k−2
B: ð2Þ
Here, k1 and k−1 are the desorption and insertion rate constants for
cholesterol into membrane A, respectively. The aqueous sterol fraction
is indicated by ‘water’. For membrane B, k2 is the insertion rate constant
and k−2 is the corresponding desorption rate constant. Typical
experimentally determined values for DHE insertion into and desorp-
tion from POPC membranes are k2 = 5.1 ∙107 M−1∙s−1 and k−2 =
1 ∙10−3 s−1 [95]. The equilibrium constants for the individual steps in
Eq. (2) are given by q1= k1/k−1 and q2= k2/k−2, respectively.Whether
aqueous or collisional transfer dominates for cholesterol is still debated
due to cholesterol's low water solubility [87,96]. For example for DHE,
the partition coefﬁcient between water and POPC liposomes has been
estimated after normalizing to phospholipid concentration to q =
1.3 ∙106 corresponding to 13 million DHE molecules in the membrane
for one molecule in water [95]. At increasing concentration of acceptor
membranes, sterol transfer seems to be dictated by the frequency of
vesicle collisions [96]. After sufﬁcient time, the cholesterol distribution
betweenmembranes A and Bwill be independent of the aqueous sterol
pool, anyway, according to:
K ¼ q1  q2 ¼
water
A
 B
water
¼ B
A
¼ k1  k2
k−1  k−2 : ð3Þ
Thus, cholesterol solubility in the aqueous phase might play a role
for the kinetics of sterol transfer between membranes but not for the
equilibrium distribution. Accordingly, we can ignore an eventual inter-
mediate cholesterol pool between the membranes in what follows. At
thermodynamic equilibrium cholesterol's chemical potential, μChol,
deﬁned as change in Gibbs free energy due to an inﬁnitesimal change
in cholesterol abundance according to the Gibb–Duhem equation, is
identical in both membranes, i.e.
μAChol ¼
∂G
∂nAChol
¼ μA;0Chol þ kb  T  lnxAChol≡μBChol ¼
∂G
∂nBChol
¼ μB;0Chol þ kb  T  lnxBChol: ð4Þ
Here, kb is Boltzmann's constant and T is temperature. The partition
coefﬁcient of cholesterol between both membranes, assuming ideal
mixing, will therefore become
K ¼ x
A
Chol
xBChol
¼ exp
− μA;0Chol−μ
B;0
Chol
 
kb  T
0
@
1
A: ð5Þ
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in the respective membrane under standard conditions. This, in turn
depends on the property of the host lipid matrix in the particularmem-
branes. Lipid membranes, however, are not dilute isotropic solvents for
cholesterol, but instead crowded, anisotropic media withmany internal
degrees of freedom. If we want to take such effects into account, we can
introduce the activity coefﬁcient, γ, leading to a modiﬁcation of the
expression for the chemical potential:
μChol ¼ μ0Chol þ kb  T  ln xChol  γChol: ð6Þ
From that, we deﬁne an apparent equilibrium constant, K′, as:
K 0 ¼ γ
B
Chol
γAChol
 K: ð7Þ
The activity coefﬁcient for cholesterol determines the free volume
accessible for cholesterol in each membrane [97]. Thus, if for example,
γCholB = 5 ⋅ γCholA because the available volume for cholesterol in mem-
brane A made of saturated PC is several-fold that in membrane B
made of unsaturated PC, membrane A could accommodate ﬁve times
the amount of cholesterol compared to membrane B at equilibrium.
For many membrane solutes, the activity coefﬁcient can be directly
related to thework required to create a cavity for themolecule in the bi-
layer, as can be derived from scaled particle theory [97,98]. However,
cholesterol reduces the available free volume in the bilayer, and
consequently, lowers drastically the membrane permeability for many
solutes [99–101]. So, why would a membrane consisting of saturated
PC molecules accommodate more cholesterol than a membrane made
of unsaturated PC? The answer lies in cholesterol's condensing effect
on phospholipid bilayers, a well-known phenomenon tracing back to
experimental mapping of binary phase diagrams of PC and cholesterol
and their theoretical interpretation [102,103]. Due to its planar, non-
polar structure, cholesterol reduces the conformational space available
for fatty acyl chains, thereby reducing their area requirement under
the PC head groups [103–105]. In membranes made of unsaturated
PC, however, higher ﬂexibility of the kinked fatty acyl chains prevents
equally tight packingwith cholesterol. Consequently, the space require-
ment of the non-polar bilayer region (i.e. sum of fatty acyl chains and
cholesterol) in a membrane is higher, if the host phospholipid is unsat-
urated PC (e.g. DOPC inmembrane B) than if it is saturated PC (e.g. DPPC
in membrane A). Since both membranes have the same head group,
more cholesterol gets exposed to the interfacial area in membrane B
compared to membrane A, thereby making unfavorable contacts with
water. Exposure of cholesterol to water lowers the entropy of the
watermolecules in vicinity of the sterol, which gives a positive contribu-
tion to the Gibbs free energy (i.e. the free enthalpy). This is therefore
highly unfavorable, and there is a tendency to shield sterols under
phospholipid head groups to lower the total free enthalpy. The efﬁcien-
cy of this shielding, though, depends also on the ability of cholesterol to
pack with the adjacent phospholipid acyl chains, which in turn are
ordered by the presence of cholesterol. The same reasoning applies to
other host lipid species, as for example, the amount of sphingolipids
will positively correlate with the partition preference of cholesterol in
a given membrane [89,90,106]. Instead of free-volume theory, as for
other membrane solutes, the extent of sterol tilt seems to be an ade-
quate measure for cholesterol's effects on membrane properties [107,
108]. The lower the tilt, i.e. the more cholesterol is aligned with the bi-
layer normal, the larger is the extent of membrane condensation and
the stronger is the interaction with the fatty acyl chains of the host
phospho- or sphingolipids. A low tilt means also high mechanical
stability and thickening of the membrane, thereby likely affecting
protein interaction with the bilayer [107–110]. Equally important, a
low sterol tilt in the membrane is associated with lowered propensity
for sterol ﬂip-ﬂop, which has been suggested to involve rotation of the
sterol perpendicular to its long axis [111,112]. The sterol tilt does notonly depend on the host lipid composition but also on the sterol type
and mole fraction in the bilayer. In full accordance with that are recent
experiments and theoretical studies showing i) faster ﬂip-ﬂop and
higher tilt of ketosterols than cholesterol [113], ii) decreasing cholester-
ol tilt for increasing cholesterol mole fraction in the membrane [108,
114], iii) higher partitioning of cholesterol in cholesterol-rich PC than
in cholesterol-poor PC membranes [111,115,116] and iv) decreasing
ﬂip-ﬂop rates of cholesterol for increasing membrane cholesterol
content [111].
Taken together, the speciﬁc properties of the hostmembrane includ-
ing phospho- and sphingolipid composition and sterol content deter-
mine cholesterol's chemical activity in the respective membrane
allowing for differing sterol mole fractions in two bilayers at thermody-
namic equilibrium (Eq. (7)). Deviation from thermodynamic equilibri-
um upon a small perturbation will cause a non-vesicular sterol ﬂux
between both membranes. This ﬂux is proportional to the difference
in chemical potentials betweenbothmembranes (i.e. toΔμChol= μCholA −
μCholB ). Thus, the chemical potential difference of cholesterol between
the membranes acts as thermodynamic driving force for sterol ﬂux
and this ﬂux vanishes at equilibrium when ΔμChol approaches zero.
This connection between differences in chemical potential and ﬂux is
called a linear ﬂux–force relationship in linear irreversible thermody-
namics and can be derived from a Taylor expansion of the ﬂux with re-
spect to the force around a reference state. Of course, lipid membranes
are anisotropic solvents, causing additional terms in theGibbs free ener-
gy change associated with sterol transfer [98,114]. In contrast, classical
partition experiments upon which the above formalism is based use
an oily phase, made of isotropic solvents as alkanes with no preferred
orientation of the hydrocarbon chains. In cells, proteins could addition-
ally affect the cholesterol solubility of membranes, as could be shown
for transmembrane peptides affecting the partition coefﬁcient of ﬂuo-
rescent sterols as CTL or TopFluor-cholesterol between liposomes [117].
3.2. How do membrane properties of cholesterol relate to its intracellular
transport?
Several lines of evidence indicate that intracellular sterol ﬂux be-
comes non-linearly dependent on the membrane sterol mole fraction.
For example, above certain threshold concentrations of total cell choles-
terol a non-linear raise in cholesterol content in the ER accompanied by
a halt in SREBP2 activation and acute proteolytic inactivation of HMG-
CoA reductase has been observed [4,6,7]. An increase of cellular choles-
terol beyond some threshold causes also abrupt stimulation of choles-
terol esteriﬁcation by ACAT [5,7], sudden acceleration of cholestenone
formation by cholesterol oxidase and enhanced extractability of choles-
terol with cyclodextrin [7,118], accelerated DHE inﬂux in ATP-depleted
macrophages [34] and increased accessibility of cholesterol to PFO
binding [51,57]. These observations cannot be explained by a linear
ﬂux–force relationship, since they point to a non-linear increase of
μChol at critical cholesterol mole fractions. Three physico-chemical
models have been invoked to explain such sudden changes in μChol at
critical cholesterol mole fractions. In all models, as in our considerations
above, two membranes can have largely differing cholesterol amounts
and still be in thermodynamic equilibrium. In the superlattice model,
cholesterol is supposed to prefer regular packing geometries in the
phospholipid matrix due to a mismatch in the cross-sectional area of
the different lipid species [119]. This causes long-range repulsive forces
between cholesterol molecules and sudden spikes in μChol at critical
mole fractions of the constituents, where preferred packing geometries
are disturbed [120]. In the umbrella model, cholesterol is believed to
avoid contacts with water due to its small polar OH-group resulting in
preferred association with certain membrane phospholipids, which
can shield the sterol under their head groups [121–123]. Due to increas-
ing order of the fatty acyl chains and consequently condensing of the
membrane, the ability to ‘hide’ cholesterol under the phospholipid
head group diminishes as a non-linear function of cholesterol
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teractions in the energy functional and predicts several jumps in μChol
at particular packing geometries of phospholipids and cholesterol at
high sterol mole fractions in the bilayer [121,122]. Each jump in μChol
corresponds to a transition from one type of a regular cholesterol distri-
bution to another. In the third model, the condensed complex model,
stoichiometric interactions are assumed between cholesterol and phos-
pholipids with saturated fatty acyl chains, called reactive phospholipid
(e.g. DPPC), while no complex formation is assumed for unsaturated
phospholipids (called ‘unreactive’; e.g. DOPC) [124]. The expression
for the Gibbs free energy of the system contains an ideal term and a
mixing term for all four species (i.e. cholesterol, reactive and unreactive
phospholipid and the complex formed between reactive lipid and cho-
lesterol). From a thermodynamic analysis of this system and its temper-
ature dependence deuterium NMR quadrupole splittings and order
parameters were predicted, and phase diagrams were constructured
[124,125]. The non-linear behavior in that model stems from formation
of higher order complexes implying some form of cooperativity
between cholesterol and certain phospholipid species [126,127]. The
condensed complex model predicts a jump in μChol at a stoichiometric
composition for a particular cholesterol fraction (i.e., 33 mol% to
45 mol% cholesterol, dependent on the exact model parameters).
Recently, many observations made on living cells are interpreted
based on the condensed complex model by conjecturing two pools of
cholesterol to reside in each intracellular membrane, a free, that is
non-complexed and a lipid-complexed cholesterol pool [4,127–129].
The equilibrium constant between both intra-membranous pools is set
by the differing cholesterol afﬁnity of the host lipids in that model
[127,128]. The non-complexed pool, increasing substantially above the
threshold concentration, is sometimes called ‘active cholesterol’ [129].
Although intriguing and certainly an attractive view point for under-
standing cellular homeostatic responses [9], several questions remain,
as for example the physical identity of the active and condensed choles-
terol pool in a biological membrane are not clear. Even though the
authors of the condensed complex model emphasize, that observation
of sudden increases in μChol in amembrane do not require phase separa-
tion [124,125], suggestive ﬁgures in recent reviews on sterol transport
indicate two lateral sterol pools (i.e., non-complexed and complexed)
in cellular membranes [128,130,131]. However, lateral microscopic
sterol-enriched domains have never been observed in membranes of
living cells. In fact, recent results show a homogeneous lateral distribu-
tion of cholesterol and its ﬂuorescent analogs in the PM of living cells
[19,132–134]. This was supported by high resolution secondary ion
mass spectrometry reporting that cholesterol is homogeneously distrib-
uted and not enriched in SM domains in the PM of ﬁbroblasts, even
though the cells were ﬁxed using glutaraldehyde in these experiments
[134]. Stimulated emission-depletion based FCS allowing for testing of
diffusion laws by spot-size variation found free diffusion but no
trapping of TopFluor-cholesterol and other dye-tagged cholesterol
probes down to less than 80 nm in the PM of living cells [19,135].
Thus, if cholesterol forms indeed lateral inhomogeneities in cellular
membranes, such domains must be highly dynamic and very small
with diameters much less than 80 nm [19,136]. Interestingly, Monte
Carlo simulations and recent neutron scattering experiments indicate
cholesterol-PC domains in binary mixtures at high sterol mole fractions
with an upper diameter of 22 nm and an average lifetime of 100 ns [52,
70]. Currently, no experimental technique is available to determine
whether cholesterol forms similar domains in membranes of living
cells. Could the two PM leaﬂets resemble the active versus condensed
or restrained cholesterol pools? While this cannot be ruled out, the
known rapid sterol ﬂip-ﬂop in lipid membranes as well as the numbers
found in recent studies with only about 30% sterol in the SM-rich outer
leaﬂet and themajority of sterol in the likely less packed inner leaﬂet of
the PM make this explanation also questionable [79,106,137]. The pre-
diction of jumps in μChol in the condensed complex and in the umbrella
model, as applied to bilayers, occur for particularly high cholesterolmole fraction (i.e., about 40–50 mol% depending on the exact parame-
ters used for lipid interaction potentials) [123,124]. At these concentra-
tions, a given membrane might simply have reached its capacity to
solubilize cholesterol, in which case the ‘active’ cholesterol pool would
resemble excess cholesterol beyond the membrane solubility limit
[122]. The cholesterol solubility limit depends of course on the phos-
pholipid head group and the acyl chain length and saturation, such
that all arguments of the above analysis apply. Above the solubility
point, cholesterol would precipitate from the bilayer in form of crystals
[122], unless other acceptormembraneswith remaining capacity to sol-
ubilize cholesterol or soluble LTPs are available in the system. Thus, the
active cholesterol could simply resemble partly water-exposed choles-
terol, which cannot be shielded under phospho- and sphingolipid
head groups and needs to be exported to othermembranes for lowering
the total system Gibbs free energy. Experiments on acutely cholesterol-
loaded cells support that view, since the cholesterol content of intracel-
lular membranes increases rapidly up to ﬁve-fold under these
conditions [138]. Also, non-vesicular DHE inﬂux to lipid droplets and
other membranes as well as efﬂux to cyclodextrin is enhanced in
cholesterol-loaded murine macrophages [34]. Interestingly, these cells
do not sequester excess sterol in domains in the PM [133], but rather
stimulate their PC synthesis to generate moremembrane for accommo-
dation of excess sterol [139]. After prolonged cholesterol loading in such
macrophage foamcells cholesterol crystals have been observed, indicat-
ing that the sterol solubility limit of all membranes has been passed
[140,141]. Neutron scattering experiments support the view, that
cholesterol can partially protrude from the bilayer, especially at high
mole fractions [142]. Recent molecular dynamics simulations indicate
that the distance of cholesterol's hydroxyl group from the bilayer center
diminishes non-linearly for high sterol mole fractions [143]. This par-
tially protruding cholesterol could resemble the active cholesterol pool
without need for separate domains. Increased transverse excursion of
cholesterol at highmole fractions could resemble the onset of cholester-
ol precipitation unless being picked up by LTPs to trigger non-vesicular
sterol exchange to a given acceptor membrane. Several other thermo-
dynamic models have been put forward to explain binary and ternary
phase diagrams of cholesterol and phospholipids; for example [102,
103,144–146]. Not all of them invoke formation of condensed com-
plexes, indicating that existence of complexes is not a requirement for
the observed mixing characteristics of cholesterol and phospholipids.
Such models do not attempt to relate the proposed biophysical mecha-
nisms of cholesterol-phosholipid interactions to cholesterol transfer
between membranes. This could be an interesting topic for future
research.
Interesting but also somehowcontradictive evidence for the hypoth-
esis of ‘active’ cholesterol comes from recent studies using the choles-
terol dependence of PFO binding to model and cellular membranes as
readout for changes in μChol in the bilayer. Inmodel and cellmembranes,
there is a threshold concentration of cholesterol abovewhich binding of
PFO and its derivatives becomes detectable [147,148]. This threshold
does not seem to relate to cooperative oligomer formation of the
proteins, since it also occurs for truncated PFO variants not forming
oligomers [149]. For the PMof intact cells, the threshold for PFO binding
is around 35% cholesterol, while for ER membranes this threshold is
only 5 mol% cholesterol [4,148]. Intriguingly, the latter value coincides
exactly with the threshold for SREBP2 processing and nuclear targeting
as a switch for regulating cholesterol homeostasis [4,150]. Based on
these observations, it has been proposed that the threshold for PFO
binding resembles the jump in μChol, as predicted in the condensed
complex and umbrella model [143,147,148]. In strong support of this
argument is the sequence of threshold cholesterol concentrations for
PFO binding to PC model membranes of varying acyl chain saturation
ranging from about 35mol% for DOPC over 45mol% for POPC to approx.
49 mol% for DPPC [143,147,148]. Also, the mean depth of cholesterol's
hydroxyl group in MD simulations coincided convincingly with the
PFO binding afﬁnity measured in the same study [143]. Neither
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isotropy nor detergent solubility correlated with the threshold of PFO
binding [147]. Thus, one can argue that PFO detects the ‘active’ choles-
terol pool in themembrane, when the bilayer approaches its cholesterol
solubility limit [143]. The extremely low threshold value for PFO bind-
ing to ER membranes, however, could not be reconciled in any model
membrane experiment and cannot be explained by the condensed
complex model, either [4]. Since the same threshold was observed for
liposomes made from ER lipids, a speciﬁc role of ER proteins can be ex-
cluded [4]. Liposomes made of ER lipids should have bulk biophysical
properties (i.e. ﬂuidity, bending rigidity andmicroviscosity) resembling
those of liposomes made from unsaturated PC species, as DOPC [89,91,
151]. Thus, the very different threshold values for cholesterol accessibil-
ity of liposomes made of DOPC compared to those made of ER-derived
lipids as measured by PFO binding remains enigmatic [4]. Since some
cholesterol-dependent cytolysins require cholesterol in bothmembrane
leaﬂets [152], and cholesterol might form transbilayer dimers at very
low concentrations [75,153,154], a speciﬁc transverse cholesterol orga-
nization in the ERmembranemight be responsible for the low threshold
in PFO binding. Alternatively, PFO binding might require a speciﬁc lipid
co-factor found in the complex mixture of ER lipids but not in model
membranes. Quantitative lipid mass spectrometry of puriﬁed ER
membranes might help to clarify this issue.
In the PM of living cells additional leaﬂet-speciﬁc cholesterol–lipid
interactions might be at play in regulating sterol transport and trigger-
ing physiological responses to control cholesterol metabolism. For ex-
ample, the majority of SM and all glycosphingolipids will be restricted
to the outer PM leaﬂet. Treatment of ﬁbroblasts with bacterial
sphingomyelinase (SMase) causes the formation of ceramide in the
PM paralleled by rapid ATP-independent cholesterol transport to and
esteriﬁcation in the ER [155,156]. The same treatment increases choles-
terol efﬂux to cyclodextrin, while degradation of PC with a speciﬁc
phospholipase had a much lower effect on this process [157]. SMase
treatment also triggered energy-independent formation of endocytic
vesicles which, however, do not appear to be enriched in PM-derived
sterol [34,158]. These observations can be explained by a preferred in-
teraction of cholesterol with sphingolipids, as discussed in Section 3.1.,
above and further reviewed elsewhere [159]. Consumption of SM as
substrate in the SMase-catalyzed reaction would reduce the number
of cholesterol-SM pairs, thereby weakening cholesterol interactions in
the PM. Alternatively, the non-polar reaction product, ceramide, com-
petes with cholesterol for shielding by phospholipid head groups and
pushes cholesterol out of the bilayer above some critical concentration.
This explanation is fully in line with the umbrella model, described
above and further substantiated by several experimental studies. For ex-
ample, ceramide replaces cholesterol from ordered domains in model
membranes and triggers cholesterol precipitation into the crystal
phase [160,161]. The maximum solubility of cholesterol in the latter
study decreased concomitantly with the increase in ceramide concen-
tration, completely in line with the umbrella model of cholesterol–
lipid interactions. Ceramide also directly competes with cholesterol for
association with SM in model membranes [86]. A recent study
combined the PFO binding assay with SMase treatment of cells and
other biochemical assays on human ﬁbroblasts incubated with LDL
[162]. PFO bindingwas increased after incubating cells with LDL for sev-
eral hours, and this effect was enhanced when cells where treated with
SMase prior to PFO binding. Similarly, SMase caused increased choles-
terol esteriﬁcation, in agreement with earlier results [155,156,162].
The authors argued that three pools of cholesterol exist in the PM;
1) a PFO-detectable pool comprising about 15 mol% of PM lipids,
which is expandedupon LDL uptake. The other two pools are according-
ly not accessible to PFO and were suggested to resemble 2) a SM-
sequestered pool and 3) a so-called essential pool, not responding to
any treatment but being important for cell viability. As discussed
above for the ‘active’ vs. lipid-complexed cholesterol pool, the physical
nature of these biochemically deﬁned cholesterol pools remains to bedetermined, especially in light of accumulating evidence for a homoge-
neous lateral cholesterol distribution in the PM [162–164].
Experiments with collisional quenchers and intrinsically ﬂuorescent
cholesterol analogs suggest that the majority of cholesterol resides in
the inner leaﬂet of the PM. This is a striking but also puzzling observa-
tion given the evidence for preferred interaction of cholesterol with
SM and other sphingolipids in the outer leaﬂet (see above). However,
evidence for preferred enrichment of cholesterol in the inner leaﬂet
has been provided also in othermuch earlier studies [165–167]. Recent-
ly, a model has been put forward which suggests that cholesterol is
drawn to the inner leaﬂet by the high abundance of PE in this leaﬂet
[168]. PE has a small headgroup and by itself a high spontaneous curva-
ture forming inverted hexagonal phases at physiologic temperature due
to dominating entropy of its fatty acyl chains. This causes a strong bend-
ing energy being quadratic in the PE concentration, which would be
counteracted by cholesterol [168]. At ﬁrst glance, this suggestion is in
contradiction to partition experiments, in which cholesterol has a
lower afﬁnity for liposomes made of PE compared to those made of PC
and SM (see Section 3.1., above) [90]. However, the important point in
themodel by Giang and Schick (2014) is the asymmetric PE distribution
in the membrane causing an energy penalty due to negative bending
and PE's spontaneous curvature [168]. Since cholesterol is shielded
under the PE head group in accordance with the umbrella model, the
spontaneous curvature caused by PE'smolecular shape gets compensat-
ed when cholesterol is ﬂipped to the inner leaﬂet [121,168]. The model
predicts about 48-58% of PM cholesterol in the inner leaﬂet, depending
on the parametrization of the spontaneous curvature. These modeling
results are in linewith earlier theoretical studies on phospholipid trans-
location in the erythrocyte membrane by an ATP-dependent
translocase, which also predicted about 50% of cholesterol in the inner
leaﬂet [169]. Active translocation of PE and PS or adding exogeneous
SM to the membranes outer leaﬂet would cause a transient increase of
cholesterol in the inner leaﬂet to compensate for any area imbalance.
Thus, fast cholesterol ﬂip-ﬂop in the PM could be an efﬁcient mecha-
nism for keeping the difference in lipid numbers between both leaﬂets
small, especially under non-stationary conditions due to membrane fu-
sion or bending [169]. The latter is indeed supported by experiments
[170].
Taken together, passive processes and speciﬁc cholesterol–lipid in-
teractions play a dominant role in cholesterol movement and distribu-
tion in the cell, especially when cellular cholesterol exceeds some
threshold concentration. Understanding the detailed nature of such
cholesterol–lipid interactions in individual cellular membranes and
the speciﬁcity of LTPs carrying cholesterol along seem to be the key
aspects in determining the control of non-vesicular sterol transport in
cells. How other biophysical properties of cellular membranes, as pro-
tein content [117], free fatty acids [171] or bilayer curvature [153,154,
170] affect inter-organelle cholesterol transfer remains open. Similarly,
understanding the impact of constant vesicle trafﬁcking and ATP-
consuming lipid remodeling on non-vesicular sterolﬂuxes awaits future
research.
4. Protein-mediated uptake, intracellular targeting and efﬂux of
cholesterol
In the following, we will give an overview of several cholesterol
transport pathways and their protein dependence in living cells.
We will focus on mammalian cells, since several excellent reviews
have recently discussed sterol trafﬁcking in yeast and other organisms
[56,130,172].
4.1. How lipid transfer proteins mediate non-vesicular sterol transport —
two examples
Several cases of non-vesicular cholesterol transport in cells have
gained a lot of interest and insight in the last decades. One example is
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volves StAR on the mitochondria and cholesterol-donating StARD3/
MLN64 and NPC2 on late endosomes (LEs) [173–175]. StAR and MLN-
64 are both involved in cholesterol transport, and they were found to
contain the same domain named steroidogenic acute regulatory-
related lipid transfer (START) domain. The START domain of MLN64
and StAR was shown to bind cholesterol at an equimolar ratio [77].
The C-terminal domain of MLN-64 contains 37% amino acids identical
to the StAR protein and nearly 60% of amino acids, which show similar-
ities to StAR [176]. Little is known about the mechanistic details of this
transport route, and current knowledge has been reviewed elsewhere
[173,174]. Another case is transport of cholesterol from the ER, where
cholesterol is synthesized, to the cell surface and the third case is choles-
terol import from the PM to the ERC and ER. We will consider these lat-
ter two processes in the following section and use them for delineatingFig. 1. Possible mechanisms underlying non-vesicular sterol transport by transfer proteins. A, p
molecule performs a random walk from the donor membrane (left) to the acceptor membran
process is likely very inefﬁcient and requires transfer proteins to take place at signiﬁcant rates. 2
dm, before it gets reabsorbed by the donor membrane. The deﬁnition of dm is given in Eq. (8) of
branemight bind the sterol transiently allowing for its lateral diffusion in thatmembrane and de
as to enable the sterolmolecule to travel to the acceptormembrane, where it gets inserted (smi
somehow by allowing for transient absorption of the sterol, but this is not sufﬁcient to preven
between the membranes is given in units of dm. If d b dm the sterol molecule can move to the a
gime, sterolﬂux is limited bypartitioning of sterol between themembranes. For inter-membran
C, D, soluble transfer proteins (i.e., carrierswhich do not interact withmembranes; case (1)— u
C). In case (2), membrane-binding transfer proteinswill increase both, dm and Jmax (cyan dotted
together, thereby increasing Jmax and pulling themembranes to a distance d ~ dm, such that diff
lower part of panel D).
Adapted from [187].basic principles of LTPs function in sterol transport. De novo synthesized
cholesterol trafﬁcs to the PM in about 10 min, largely bypassing the
Golgi apparatus [16,28,177,178]. This transport required ATP and
stopped below 15 °C, while maintenance of the established cholesterol
gradient between PM and ER was independent of metabolic energy
[16,28]. Thus, vesicular and non-vesicular transport modes seem to be
at play for export of cholesterol from the ER. Sterol exchange between
ER and Golgi depends on the activity of OSBP, whose two structural
motifs create membrane contact sites between both organelles. The N-
terminal plekstrin homology (PH) domain binds to phosphatidyl
inositol-4-phosphate (PI-4-P) in the TGN, while the FFAT (two phenyl-
alanine in an acid tract) motif binds to VAMP associated protein (VAP)
in the ER [56,81]. The OSBP-related domain (ORD) of the protein
transfers sterols between both membranes, as suggested by in-vitro
experiments, in which about 30 DHE molecules were transferred perossible outcomes of desorption of a cholesterol molecule from a donor membrane: 1) The
e (right), where it gets inserted giving a successful excursion, indicated by a smiley. This
) The cholesterol molecule desorbs and diffuses up to approx. its mean excursion distance,
the main text. 3) Membrane structures located in between the donor and acceptor mem-
sorption closer to the acceptormembrane. Together, this allows for extending dm somuch
ley). 4) An intermediate membrane, as there are plenty in the cytoplasm, might extend dm
t its reabsorption by the donor membrane. B, Sterol transport rate as function of distance
cceptor membrane approaching the maximal ﬂux, Jmax, for very short distances. In this re-
e distances larger than dm the diffusion constant of cholesterol in themedium limits itsﬂux.
pper part in panel D) will increase dm several foldwithout changing Jmax (red dotted line in
line in C andmiddle part of panel D). In case (3), transfer proteins tether twomembranes
usion will never limit the net sterol ﬂux betweenmembranes (orange dotted line in C and
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Addition of 25-hydroxycholesterol to cells recruits OSBP to the Golgi in-
terface, while the PH-FFAT region induces tethering and formation of
several membrane appositions of about 20 nm distance between ER
and PM [81]. Such close apposition will enhance the likelihood of sterol
transfer instead of reabsorption by the donor membrane (see Fig. 1 and
below) [179]. TheORDbinds and transfers not only sterols but also PI-4-
P, and amodel has been put forward, in which ATP-consuming hydroly-
sis of PI-4-P in the ER by Sac1 drives directional lipid exchange between
both organelles [81]. Further information about the function of OSBP
and other family members in lipid transfer can be found in recent
review articles [56,130,180]. Establishment of membrane contact sites
by a putative sterol transporter has been recently also observed
between LEs and the ER via interaction of MLN64 with VAP [181]. This
result suggests that MLN64 can catalyze non-vesicular sterol transfer
between these organelles by a similar mechanism, as proposed
for OSBP (for further details on cholesterol transport from LEs, see
Section 4.3. and Fig. 3, below).
Compelling evidence for non-vesicular sterol transport from the
PM came from imaging studies of DHE in TRVb1 cells, a Chinese
hamster ovarian (CHO) cell line expressing the human transferrin
receptor [13]. DHE was inserted into the PM from a cyclodextrin
complex, and sterol transport to the ERC was studied. Interestingly,
energy-poisoning reduced the steady state level of DHE in the ERC
only by 30%, and transport of DHE to the ERC continued even after
cell ﬁxation [13]. A simple ﬂux–force relationship can explain these
observations, as long as the inﬂux rate is proportional to the size of
the perturbation. Here, a strong gradient of ﬂuorescent sterol is
established at the moment, the tracer DHE is added to the cells
(i.e., pulse-chase conditions; Section 3.1., above). Note, that in this
experiment DHE is exchanged against PM cholesterol, such that
overall sterol equilibrium should not be perturbed. Speciﬁc proper-
ties of the endosomal membranes might create a sink for sterol
transport resulting in DHE entrapment in the ERC [13]. This
could be a consequence of the speciﬁc lipid composition of this
organelle, as discussed in Section 3.2. Non-vesicular cholesterol
transport between PM and ERC/ER was found to be accelerated by
overexpressing some LTPs, as SCP2, liver-speciﬁc FABP and ORP2,
an OSBP homologue, as well as StARD4 [14,85,182–184]. The abun-
dance of StARD4 had a pronounced effect on DHE targeting to
the ERC and ER, on cholesterol esteriﬁcation and on proteolytic pro-
cession of SREBP2 [14]. FRAP experiments have shown that DHE
transport to the ERC was rapid and largely ATP-independent with a
half-time of t1/2 ~ 2.5 min in TRVb1 cells [13]. Reduced expression
of StARD4 but not its over-expression slowed also the FRAP kinetics
of DHE in the ERC of HepG2 cells and resulted in increased free
cholesterol in the PM [185]. Importantly, injection of cyclodextrin
mimicked the effects of StARD4 including acceleration of DHE trans-
fer between PM and ERC [14]. In vitro, sterol transfer by StARD4 and
by SCP2 was enhanced in the presence of negatively charged lipids,
which likely interact electrostatically with surface residues on the
proteins [14,186]. StARD4 was also more efﬁcient than cyclodextrin
in transferring DHE between liposomes, when comparing the same
carrier concentrations [14].
Given the extremely low water solubility of cholesterol, pulling one
cholesterol molecule out of a bilayer into water requires overcoming an
energy barrier of 80–90 kJ/mol corresponding to hydrolysis of about 1.5
ATP molecules [111]. So, what is the molecular mechanism underlying
enhanced interbilayer sterol transport by these LTPs? Rapid binding of
sterol to LTPs after cholesterol desorption from the bilayer would
prevent reinsertion of the sterol into the donor membrane. The average
distance, a cholesterol molecule diffuses into water before rebinding to
the donor membrane can be quantiﬁed as mean diffusional excursion,
dm, as proposed in a steady state transport model developed by
Weisiger and Zucker (2002) to describe cytosolic fatty acid transport
by FABPs [179]. Applied to non-vesicular sterol transport, the presenceof a LTP with concentration [LTP] and dissociation constant for the
ligand, KD, will increase dm according to
dm ¼
2  Df þ LTP½   Db  K−1D
 
Pmw
: ð8Þ
Here, Df and Db are the diffusion constants of the free and protein-
bound sterol, respectively, and Pmw is the permeability of the mem-
brane–water interface deﬁning the rate of rebinding [179,187]. From
Eq. (8), one can see that the largest values for dm results from highly
abundant LTPswith high diffusion constants and strong binding afﬁnity.
The diffusive ﬂux between two membranes at steady state, J, was
calculated in that model as function of membrane separation distance,
d, to [179,187]:
J ¼ Jmax
1þ d=dm : ð9Þ
Here, Jmax is half the rate of sterol dissociation (desorption) from the
donormembrane, and thereby directly related to the chemical potential
difference between the membranes, as discussed in Section 3.2. For
non-zero cholesterol concentration in the donor and acceptor mem-
brane with concentration difference Δc, one gets Jmax = Δc∙Pmw/2
[187]. Thus, the maximally achievable ﬂux follows a simple ﬂux–force
relationship, as discussed in Section 3.1., inwhich the concentration dif-
ference resembles the thermodynamic force, and Pmw is the generalized
transport coefﬁcient (e.g. 1. Fick's law on diffusion) [20]. Fig. 1A illus-
trates the possible fates for a sterol molecule after desorption from a
donor membrane, while Fig. 1B shows, how the inter-bilayer ﬂux
depends on the inter-membrane distance, d. Adding a soluble LTP will
strongly increase dm, thereby preventing reabsorption of the sterol
molecule (Fig. 1C). If dm ≫ d, one sees from inspection of Eq. (9), that
the steady state ﬂux J approaches Jmax, as indeed found for
membrane-inactive LTPs (e.g., fatty acid transport by L-FABP, Fig. 1C)
[187]. If the membrane separation distance, d, is much smaller than
dm, J approaches Jmax, even without soluble LTPs, since the ﬂux in this
case is not diffusion-limited (Fig. 1B) [187]. For cholesterol, which has
a much lower desorption rate from membranes (i.e. hours, see
Section 3.1.) than fatty acids (i.e. milliseconds to seconds) [188], soluble
LTPs might be not very efﬁcient. Instead, for most known sterol carrier
proteins and even for cyclodextrin, transient interaction with the
donormembrane is instrumental for catalyzing inter-bilayer cholesterol
transfer [14,186,189,190]. In their pioneeringmodeling study, Weisiger
and Zucker (2002) also determined the impact of membrane interac-
tions of the LTPs on steady state ﬂux of fatty acids [179,187]. They
showed that transient membrane associations of the LTPs also affects
Jmax, as they lower the Gibbs free energy barrier for sterol desorption
and thereby increase the permeability at the membrane–water inter-
face, Pmw (Fig. 1D). Interaction of LTPs with certain cellular membranes,
either due to electrostatic interactions with acidic lipids as shown for
StARD4or due to dual bindingmotifs to proteins residing in different or-
ganelles as known from OSBP fall into this category [14,81]. Membrane
interaction of a LTP will therefore not only raise speciﬁcity but also in-
crease the inter-bilayer sterol ﬂux even if the membrane–membrane
distance, d, is smaller than themean diffusional excursion, dm. Interest-
ingly, membrane-interacting LTPs as StARD4 show up to thousandfold
higher per-molecule transfer activity of compared to cyclodextrin [14].
Similarly, absolute rates of intralysosomal sterol transfer by NPC2 are
higher than for cyclodextrin [191]. As in case with StARD4, NPC2 was
found experimentally to interact at least transiently with membranes
[190]. Molecular simulations including free energy calculations suggest
also absorption of cyclodextrin to membranes [189], but whether this
interaction is weaker compared to StARD4 or NPC2 awaits further
comparative studies. Dual binding motifs to the donor and acceptor
membrane, as found in OSBP or as recently suggested for tethering LEs
to the ER via MLN64, might be a particularly efﬁcient way of raising
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interbilayer distance by creating close membrane contact zones [56].
Via such membrane contacts, a situation might be generated in which
dm ~ d, such that monomeric sterol diffusion is not limiting and very
efﬁcient sterol ﬂux between organelles is ensured (Fig. 1C and D, case
(3)).
4.2. Cholesterol endocytosis and its functional importance
In addition to non-vesicular transport described above in
Section 3.2., cholesterol trafﬁcking between PM and ERC takes place
by vesicle trafﬁc as well. For example, recycling of DHE from the ERC
back to the cell surface required the vesicle export machinery involving
the Rme-1 protein and occurred with a half-time of about 24 min in
TRVb1 cells [13]. Transport of DHE from the PM to the ERC studied in
pulse-chase experiments in the same study reached steady state values
after about 15 min, which was similarly found in macrophages and
human hepatoma HepG2 cells [17,34]. Similarly, transport of DHE to
the ERC took place with a half time of about 8 min in rat hepatoma
cells [45].We compared recentlymembrane partitioning and intracellu-
lar transport of DHE with that of TopFluor-cholesterol and showed that
both sterols are targeted to the ERC of Baby hamster kidney (BHK) cells
with identical kinetics [42]. Uptake of both sterols from the cell surface
was strongly reduced in BHK cells overexpressing a dominant-negative
clathrin heavy chain and after ATP depletion, suggesting that clathrin-
dependent endocytosismakes a signiﬁcant contribution to overall sterol
uptake in these cells. Similarly, Ge et al., found that uptake of cholesterol
from the plasmamembrane of rat hepatoma cells depended on clathrin
and required expression of human Niemann–Pick C1 like 1 (NPC1L1)
which directly interacted with clathrin heavy chain in this study [192].
NPC1L1 is a target of ezetimibe, a cholesterol absorption inhibitor in
the intestine and is thought to play a central role in intestinal cholesterol
absorption [193,194]. The sequence and structure similarity of NPC1L1
to NPC1 including sterol binding in the N-terminal domain would
suggest a similar function of NPC1L1 in cholesterol export from early
endosomes and/or LE/LYSs [195]. This, however, was not reported so
far. NPC1L1 contains a sterol sensing domain, as NPC1 or HMG-CoA re-
ductase and binds cholesterol at its N-terminal domain [196]. NPC1L1is
found in the apical, canalicular membrane of hepatocytes and polarized
hepatoma cells, where it is highly mobile, as shown by FRAP [45,197].
This protein was found to be important for cholesterol reabsorption
from the bile compartment, probably to a subapical recycling compart-
ment, thereby regulating cholesterol homeostasis also in the liver [198].
We observed recycling of NPC1L1 between cell surface and ERC and
slightly enhanced vesicular targeting of DHE to this endocytic compart-
ment in non-polarized rat hepatoma cells [45]. However, themajority of
DHE uptake in this and other cell types takes place also in the absence of
NPC1L1. Similarly, recycling of DHE or cholesterol from the ERC to the
cell surface does not require NPC1L1, but rather depends on other pro-
teins orchestrating endocytic recycling, as the ED domain protein RME-
1 [13]. Several publications by the Song-group have provided evidence
for a microtubule-based NPC1L1-mediated endocytic net cholesterol
transport route from the PM to the ERC requiring ﬂotilin and the
clathrin adaptor Numb and for recycling of the cholesterol-NPC1L1
complex back to the cell surface in dependence of Myosin Vb, Rab11-
FIP2 and the small GTPase Cdc42 [192,199–201]. While this transport
route is likely important formaintenance of the steady state distribution
of NPC1L1, the used cholesterol transport assay is not beyond reproach;
ﬁlipin has been used to detect cholesterol replenishment from a cyclo-
dextrin–cholesterol complex, but ﬁrst after acute cholesterol depletion
of the cells for 60 min with cyclodextrin [192]. While this treatment
allowed for establishing a ﬁlipin-based pulse-chase transport assay, it
seems to be far from mimicking the demand for cholesterol absorption
in enterocytes. Thus, eventual artefacts known to be caused by
prolonged cholesterol depletion using empty cyclodextrin cannot be
ruled out [202]. Indeed, intestinal cholesterol absorption is a complexprocess, and the involvement of NPC1L1 is not without question [203].
Given the high sterol mole fraction in the PM of mammalian cells,
formation of endocytic vesicles will probably always cause some
internalization of cholesterol, likely in several endocytic pathways
(i.e., clathrin-dependent and -independent pathways). Thus, speciﬁc
sterol recruitment to a particular membrane protein, as NPC1L1, in the
PM, prior to internalization is likely not necessary for sterol endocytosis.
Indeed, we observed endocytosis of DHE and TopFluor-cholesterol by
time-lapse microscopy in cells not expressing NPC1L1 [18,46]. Due to
lack of conclusive experimental evidence, a convincing mechanistic
model on involvement of NPC1L1 in sterol uptake and transport be-
tween PM and ERC is therefore currently not available. Interestingly,
both ﬂuids from which NPC1L1 has been proposed to mediate choles-
terol absorption into cells, the digestive ﬂuid in the intestine and the
bile ﬂuid in the liver, contain cholesterol derived detergents, i.e. bile
salts. It would be interesting to study, how bile salts affect NPC1L1-
mediated cholesterol absorption into cells, thereby eventually shedding
light onto the function of this protein in these specialized tissues.
After internalization, the dynamics of vesicles carrying TopFluor-
cholesterol has been studied in CHO cells using two-photon excited
SPT [18]. Such vesicles were independently shown to contain DHE and
TopFluor-cholesterol avoiding any artefacts caused by eventual miss-
targeting of TopFluo-cholesterol [12,42]. We found that the majority
of sterol-rich vesicles moved slowly by anomalous diffusion with
D ~ 2°10−3 μm2/sα, andα ~0.6 [18]. Both, actin andmicrotubule disrup-
tion affected the diffusion of such vesicles in the cytosol. A sub-pool of
vesicles, however, showed faster, directed motion, and endosome
ﬁssion and fusion was found in time-lapse sequences of TopFluor-
cholesterol [18]. Slow conﬁned diffusion was also found for DHE-rich
vesicles by SPT on a wide ﬁeld set up in macrophages and by temporal
image correlation spectroscopy on a multiphoton microscope in
HepG2 cells [46,204]. We showed also recently that SPT and TICS pro-
vide comparable results on diffusion and directed transport of vesicles
[27]. Together, recent data suggest that under normal physiological con-
ditions sterol trafﬁcking between PMand the sterol-rich ERC takes place
on a time scale of 15 to 20min. Vesicular and non-vesicularmodes seem
to contribute each about half to that sterol transport, but exact numbers
depend on cell type and used transport assay.
4.3. Cholesterol import via low density lipoprotein and intracellular
processing of its sterol load
This section is dedicated to cholesterol import into cells via lipopro-
teins. Since lipoproteins are very diverse and their physiology is a huge
ﬁeld of research,wewill focus on the paradigmof LDL-mediated choles-
terol uptake. This pathway and its discovery represents one important
example, in which a genetic disease, here familial hypercholesterol-
emia, led to important mechanistic insights into a fundamental
biochemical process [36,205]. There are, of course, many earlier
examples in which genetic mutations were mechanistically linked to
human diseases, as sickle cell disease or phenylketonuria, but the histo-
ry of the discovery of the LDL pathway follows that tradition [206]. LDL
is about 22–27 nm in diameter, and each particle contains abundant CEs
and triacylglycerides (TAGs) in its core. The surface coat of the LDL
particle contains phospholipids (25% by weight), a single 550 kDa
apoB-100 protein (25%) and non-esteriﬁed cholesterol. TAGs, cholester-
ol and CEs represent the remaining 50% by weight of each LDL particle
[207]. LDL binds to the LDL receptor (LDL-R) at the cell surface at neutral
pH, upon which the ligand-receptor complex gets recruited to clathrin-
coated pits via interactionwith adaptor protein 2 (AP2). After endocyto-
sis and uncoating, the newly formed vesicle fuses with sorting
endosomes (SEs), a sub-population of the early endocytic pathway.
SEs lose their fusion competence for incoming vesicles and mature
into LEs, a process accompanied by a switch in endosome-associated
rab proteins, from rab5 to rab7 and by acquisition of intraluminal vesi-
cles (ILVs) (Fig. 2) [208,209]. The lysosomal pathway can be divided
Fig. 2. Schematic diagram for endosomal cholesterol transport. (1) LDL particles bind to the LDL receptor (LDL-R) at the cell surface and become internalized by clathrin-dependent en-
docytosis followed by (2) fusion with sorting endosomes (SEs). (3) in the SEs, LDL dissociates from its receptor and some hydrolysis by acid lipase starts. (4) SEs mature into late
endosomes (LEs). (5) the majority of LDL degradation including hydrolysis of cholesteryl esters to cholesterol and fatty acid occurs in LEs. LDL-liberated cholesterol can exit the LEs via
several pathways; (6a) to the Golgi/TGN in transport vesicles which fuse with the acceptor compartment via TGN-speciﬁc SNAREs (e.g. syntaxin 16); (6b) to the endoplasmic reticulum
(ER) in a pathway involving NPC2, NPC1 and ORP1L1; (6c) to mitochondria in steroidogenic cells in a pathway involving NPC2 and MLN64 but not NPC1 (a similar pathway might also
operate between LEs and ER, not shown); (6d) to the plasma membrane (PM) via a poorly deﬁned pathway. (7) some sterol follows also the normal endocytic recycling route from
SEs via the endocytic recycling compartment (ERC) to the PM. (8) from the PM, some cholesterol can be internalized by a non-vesicular mechanism involving StARD4. In this process,
cholesterol gets targeted to the ERC and ER, respectively (dashed line). Excess cholesterol arriving in the ER becomes esteriﬁed by acyl-CoA acyl transferase (ACAT) and stored in lipid
droplets (LDs). See text for further explanations.
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bodies, and lysosomes (LYSs) — acidic organelles with large content of
hydrolytic enzymes [210]. Formation of ILVs inside LEs depends on
speciﬁc lipids such as bis(monoacylglycero)phosphate (BMP), ceramide
and cholesterol. This process is also strictly dependent on the
endosomal sorting complex required for transport (ESCRT), as recently
reviewed in detail [210]. The ILVs fulﬁll diverse functions in endosome
maturation, protein degradation and lipid metabolism [210,211]. LE/
LYSs can also secrete material from cells, often in form of small vesicles
called exosomes. These secreted vesicles likely form from ILVs and have
diverse functions in cell-to-cell communication and lipid metabolism
[212]. Trafﬁc between LEs and LYSs is extensive and several theories
exist about the relation of both organelles [210]. Degradation of
ingested cargo seems to take place in LEs or hybrid organelles between
LEs and LYSs, while LYSs fulﬁll a role as enzyme reservoir [210,213].
However, as assignment of protein markers and molecular function is
not unequivocal in the literature, we will use in the following the term
LE/LYSs to address transport through the degradative organelles, unless
otherwise speciﬁed. The LDL-R contains six building domains: the bind-
ing domain, an epidermal growth factor domain (EGF), a tyrosine–tryp-
tophan–threonine–aspartic acid (YWTD) rich-domain, an O-linked
sugar domain, the transmembrane domain and the cytosolic NPxY
motif [214]. There are around 1400 LDL-R mutations known, which
lead to fatal diseases such as hypercholesterolemia, tendinous
xanthoma and premature coronary heart disease [3]. The ligand binding
domain in the extracellular portion of the LDL-R contains 7 cysteine-rich
regions, which were shown to be negatively charged. Therefore, they
can bind to positively charged residues on the apoB-100 of LDL and
VLDL. Lipoprotein binding to the LDL-R can be blocked by chemical
modiﬁcation of R1–R7 in LDL-R [3]. The extracellular domain of the
LDL-R undergoes a conformational change upon switching the pHfrom 7.4 to 5.0, which is a precondition of ligand dissociation within
SEs in cells [215]. Fass et al. (1997) showed binding of calcium ions
into the binding site on the R5 at pH = 5.0, and the crystal structure
of this complex could be resolved [216]. Recent results show that, beside
an acidic pH, low endosomal calcium is essential for release of LDL from
its receptor, likely as a consequence of structural changes in R1–R7 upon
calcium release [217].
The ligand-freed LDL-R returns to the cell surface, either directly
from SEs or from the ERC for another round of LDL uptake [208,218].
Each LDL-R can import about 120 LDL particles and thereby about
200,000CEmolecules.Within a population of LEs, acid lipase hydrolyzes
LDL-associated CEs to cholesterol and fatty acids. Lack or reduced
expression of the acid lipase causes Wolman disease and CE storage
disease, respectively [219]. These diseases are characterized by accumu-
lation of CEs in LE/LYSs. Export of the LDL-derived cholesterol from LEs
is only partly understood, but important insight came from another ge-
netic disease. NPC disease is a rare neurodegenerative disorder caused
by a mutation in one of two proteins. NPC1 protein contains several
transmembrane helices and locates mostly to LE/LYSs but is also found
in the TGN [220]. NPC2 protein is small and soluble in the lysosomal
lumen, but it is also present in several body ﬂuids including milk, bile
and epididymal ﬂuid [59,220]. Loss of function in either NPC1 or NPC2
protein has been shown to cause severe lysosomal accumulation of
cholesterol, glycosphingolipids, sphingosine, and SM [220,221]. The
resulting cellular phenotype is characterized by large amounts of
lipid-laden crescent shaped LE/LYSs, sometimes called lysosomal stor-
age organelles [220]. Fibroblasts lacking functional NPC1 protein hydro-
lyze LDL derived CEs normally but have a strongly reduced ability to
elicit normal regulatory responses, as stimulation of esteriﬁcation and
suppression of synthesis of cholesterol [59,220]. It is unclear whether
cholesterol liberated from ingested LDL is ﬁrst targeted to the PM, the
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[222]. NPC1 and NPC2 bind cholesterol, various oxysterols as well as in-
trinsically ﬂuorescent sterols like DHE with nanomolar to micromolar
afﬁnity [62,65,66,223]. Infante et al. (2008) puriﬁed and characterized
the N-terminal domain (NTD) of NPC1, later called NPC(NTD) [223].
This loop contained 240 amino acids, and it was isolated as a highly
water soluble proteinwith tendency to form a homodimer, as suggested
by gel ﬁltration [54,223]. One cholesterol molecule is able to bind to
NPC(NTD), but 25-hydroxycholesterol, was found to be favored in the
binding site in comparison to cholesterol, eventually due to formation
of additional hydrogen interactions of the oxysterol in the binding site
[223]. In fact, Infante et al. (2008) found that the majority of the
oxysterol binding protein found in the liver is NPC1 [54]. The crystal
structure of bovine NPC2 was ﬁrst determined by Friedland et al in
2003 [65]. Crystals suitable for the X-Ray experiment were grown
from NPC2 puriﬁed from bovine milk using a hanging drop method at
neutral pH stabilized by Tris buffer. The structure contains 7 β strands,
which are arranged into two β sheets. The hydrophobic interior respon-
sible for sterol binding in NPC2 is loosely packedwith an available space
for one sterol molecule (i.e. with a volume of 84 Å3 [64,65]). The
mechanisms underlying NPC1/ NPC2 function in export of LDL-derived
cholesterol from LE/LYS are not known. Mutations in both genes cause
inhibition of LDL-stimulated cholesterol re-esteriﬁcation in the ER and
failed suppression of SREBP- and LXR-dependent gene expression [224].
These defects take place despite increased total cellular free cholesterol
and are consistently more severe for mutations in NPC2. Treatment of
NPC disease ﬁbroblasts with the oxysterol, 25-hydroxycholesterol can
partially overcome the cholesterol loading in these cells [224]. It has
been proposed that NPC1 and NPC2 protein work in tandem in mediat-
ing lysosomal cholesterol export [59]. Pioneering studies by Goldstein &
Brown and co-workers published from 2008 on have shown that the N-
terminal soluble luminal domain of NPC1, named NPC1(NTD) can bind
cholesterol and oxysterols with high afﬁnity [54,223]. Ligand binding
and transfer assays showed that NPC2 can efﬁciently transfer cholester-
ol to and from liposomes, while transfer between vesicles and
NPC1(NTD) was very slow. This transfer was, however, more than a
hundredfold accelerated in the presence of NPC2 [225]. Subsequent
alanine mutagenesis studies combined with X-ray crystallography
revealed distinct subdomains in NPC1(NTD) for cholesterol binding
and transfer [63]. Key amino acids on the surface of NPC1(NTD) and
NPC2were identiﬁed for interaction of both proteins and for cholesterol
transfer [226]. The suggested hydrophobic hand-off of cholesterol
between both proteins resembles substrate channeling in metabolic re-
actions and has been investigated further using free energy calculations
based on molecular dynamics simulations [225,227]. The latter study
used an implicit solvent description based on the generalized Born
approximation and a simulation technique called nudge elastic band
calculations to suggest likely (i.e. energetically favourable) conforma-
tional transitions during cholesterol transfer between NPC1(NTD) and
NPC2 [227]. Importantly, the authors found that the protein complex
is most stable if cholesterol associates with NPC2 and least stable if
the apoproteins NPC1(NTD) and NPC2 were simulated [227]. However,
based on existing experimental and computational data, the direction-
ality of cholesterol transport between both proteins could not be
unequivocally established, yet [225,227]. The cholesterol binding
pockets of both proteins are bent with respect to each other during
cholesterol transfer in the simulation study by Wiest and colleagues,
indicating that either the sterol ligand or one of the NPC proteins
needs to change its conformation during sterol transfer (Fig. 3, inset
A) [227]. Another computational study on the NPC1(NTD)–NPC2
complex was published recently by Elghobashi-Meinhardt (2014), in
which the possibility of conformational changes in the side chain of cho-
lesterol during sliding from the NPC2-pocket to the NPC1(NTD) binding
site was explored [228]. Using a quantummechanical (QM) description
of the sterol ligand and a classicalmolecularmechanics (MM) forceﬁeld
for the proteins, the energy barrier for rotation of the C17–C20–C22–C23 dihedral angle was determined during sliding of cholesterol from
NPC2 to NPC1(NTD) (Fig. 3, inset B) [228]. This was motivated by the
earlier simulation study showing that this dihedral angle is 71.6° for
cholesterol in NPC2 but −157.3° in the NPC1(NPD) binding pocket,
while in the respective crystal structures, this torsion angle is nearly
identical with−164° [63,64,227,228]. Using QM/MM simulations, the
likely ‘reaction pathway’ for cholesterol transfer and the energy barrier
along that path was calculated giving a barrier of ~22 kcal/mol in total.
Structural changes in several torsion angles in the cholesterol side chain
were suggested to allow for its isomerization during transfer [228]. In
both simulation studies, pointmutations found in the alaninemutagen-
esis screen were found to reduce either the efﬁciency of transfer or the
stability of the complexes [63,226–228]. Additional interactions be-
tween NPC2 and other intraluminal loops of NPC1 have been recently
determined by surface plasmon resonance [229].
Despite this progress and mechanistic insight, the hydrophobic
handoff model for cholesterol transfer between NPC2 and NPC1 is
based solely on in vitro experiments but not (yet) grounded in thorough
cellular studies. For example, a direct interaction between NPC1 and
NPC2 protein has never been demonstrated in living cells. NPC1 seems
to have a rather complex distribution between several organelles in-
cluding not only LEs but also early endosomes, theGolgi and even partly
the PM [230–232]. In contrast, NPC2 is restricted to LE/LYSs, and a re-
cent quantitative imaging study showed that internalized bovine
NPC2 can remove cholesterol efﬁciently from a subset of the sterol stor-
age compartments visualized using ﬁlipin [25]. Also, export pathways
for internalized cargo from LE/LYSs have been described, which depend
on NPC2 but not on theNPC1 protein [233–235]. For example, the StAR-
domain containing MLN64 was found to export cholesterol from LE/
LYSs independent of NPC1 andwas found to reside in a distinct popula-
tion of LE/LYSs [233,236]. How such results can be incorporated into the
structural model of NPC2–NPC1-mediated cholesterol transfer
described above and in Fig. 3 is a challenge for future research. Maybe,
several exit pathways exist from LE/LYSs for cholesterol; e.g. a NPC1-
mediated route as well as a pathway dependent on MLN64-and/or the
ATP-binding cassette transporter A1 (ABCA1, discussed below in
Section 4.3.; Fig. 2). NPC2 could feed all these pathways by efﬁciently
shuttling cholesterol from ILVs to such transporters in the limiting
endosomal membrane which then transfer them to various acceptor
organelles. On the cytoplasmic side, OSBP-related protein (ORP5) and
OSBP-related protein like protein 1 (ORPL1)were additionally implicat-
ed in shuttling of LDL-derived cholesterol between LE/LYSs and the ER
[237,238]. Recent multi-color imaging studies suggest functional sub-
compartmentalization of LEs in ‘early LEs’ containing LDL, an ABC trans-
porter (ABCA3) and MLN64 and ‘late LEs’ harboring most NPC1 and
ORPL1 [236]. ORP1L1 seems to be essential to target LEs to the
perinuclear region in proximity of the ER, which would be a precondi-
tion for cholesterol transfer [237]. Again a virus trafﬁcking study provid-
ed direct evidence for concerted action of NPC1 and ORPL1 in targeting
cholesterol from LEs to the ER; adenovirus RIDα can rescue the choles-
terol storage phenotype in cells lacking NPC1 [239]. This pathway led to
increased formation of CEs derived fromhydrolysis of LDL and in forma-
tion of ER-derived lipid droplets [240]. Importantly, this transport
depended strictly on functional NPC2 supporting the view that NPC2,
NPC1 and ORPL1 act in tandem [240]. Direct observation of endocytic
processing of LDL-derived CEs was made possible using a TopFluor-
cholesteryl ester reconstituted into LDL [241]. Egress of hydrolyzed
TopFluor-cholesterol from LE/LYSs was found to depend not only on
acid lipase and NPC1 activity but also on the small GTPase rab8. This
supports earlier results by the same group showing that rab8 overex-
pression can partially restore the NPC1 lipid storage phenotype [242].
The motility of LEs containing the ﬂuorescent CE analog depended on
actin, similar as previously found again by Ikonen's group for MLN64
[243]. Members of the ESCRT family, as Hrs/Vps27, and rab7, a key
GTPase for LEs formation and positioning, are also involved in process-
ing of LDL and release of its cholesterol after CE hydrolysis [244,245].
Fig. 3.Complex between the N-terminal loop ofNPC1 (NPC1(NTD)) andNPC2 in endosomes and its suggested conformational changes allowing for cholesterol transfer. Based on the crys-
tal structure of NPC1(NTD) (PDB ID: 3GKI) and NPC2 (PDB ID: 2HKA), molecular simulations have been carried out to uncover the energetic and conformational changes associated with
cholesterol transfer from NPC2 to NPC1 [228]. A putative complex forms between NPC2 and NPC1, located in the late-endosomal lumen and limiting membrane, respectively [226]. In
NPC2, the sterol (blue stick representation) tail is buried in the binding pocket, and the 3β-hydroxyl group (red ball) extends toward the NPC1(NTD) binding site. In NPC1(NTD), the ori-
entation of the ligand (green stick representation) is reversed, with the ligand 3β-hydroxyl group (red ball) pointing toward the interior of the protein, while the isooctyl sterol tail points
toward the sterol opening. The transfer of the cholesterol ligand fromone binding pocket to the other requires a conformational change in the ligand–protein complex. One possiblemech-
anism includes the conformational rearrangement of the cholesterol ligand inside the NPC2 binding pocket (blue arrow), for example, isomerization of the cholesterol side chain dihedral
torsion angle C17–C20–C22–C23, as shown in inset (1). Via an intermediate structure (yellow), the sterol ligand could slide to the binding pocket in NPC1(NTD) (yellow to green arrow).
Inset (2) shows, how theNPC2 binding pocket (in blue) and the NPC1(NTD) binding pocket (in green) are bentwith respect to each other in this scenario during cholesterol transfer [227].
Inset (3) shows an alternative scenario in which the protein moieties are rotated with respect to each other such that the binding pockets are aligned, allowing for transfer of cholesterol
with negligible change in its conformation.
Reproduced and adapted from [228] with permission.
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derived cholesterol from LEs over the Golgi to the ER [246]. Further in-
formation about the protein machinery regulating trafﬁcking through
the endosomal pathway and thereby affecting also cellular cholesterol
homeostasis can be found elsewhere [210,222,247,248].
Some evidence has been provided that the primary offending me-
tabolite in NPC1 disease is SM, while other studies point to gangliosides
or accumulation of sphingosine (the product of ceramide degradation
by acid ceramidase) [221]. Sphingolipids, as SM, were found to block
calcium import into LE/LYSs, thereby impairing endosome/lysosome fu-
sion and lysosomal exocytosis, amechanism suggested for NPC1disease
[221,249]. Agonists of the transient receptor potential (TRP) channel in
LE/LYSs have been shown to restore normal calcium levels in LE/LYSs
(~150 μM) and to rescue the cholesterol and sphingolipid storage phe-
notype in NPC1disease cells [249]. Similar effectswere described for the
polyphenol curcumin found in yellow curry and the blocker of the ER
calcium pump thapsigargin [250]. It was speculated that lysosomal
exocytosis was stimulated by such treatments, resulting in enhanced
secretion of cholesterol-rich exosomes from the NPC1 disease cells
[251]. How calcium homeostasis is linked to function of the NPC2 pro-
tein and eventual lysosomal exocytosis remains to be determined. In
in vitro assays, NPC2 protein was found to enhance inter-membrane
cholesterol transfer in a ceramide- and BMP-dependent manner [211].
Production of ceramide from SM by an acid SMase (aSMase) seems to
be essential for cholesterol efﬂux from LE/LYSs [211,252]. In fact, treat-
ment of NPC1 disease cells with aSMase could also ameliorate the cho-
lesterol storage phenotype [252]. Similar experiments have not been
performed for NPC2 disease cells, but in vitro experiments indicate,
that NPC2 and aSMase act in concert in transferring cholesterol betweenliposomes [211,253]. However, thoughmuch argues for cholesterol, the
offending metabolite remains to be unequivocally identiﬁed.
4.4. ATP-binding cassette transporters and their role in cholesterol efﬂux
from cells
Plasma concentrations of high density lipoprotein (HDL) are nega-
tively correlated with the risk for developing cardiovascular disease.
This is, because HDL-mediated reverse cholesterol transport to the
liver is an efﬁcient way to remove excess cholesterol from the circula-
tion. Formation of HDL starts with secretion of lipid-poor apoprotein
A1 (apoA1) by the intestine and liver, and apoA1 gets subsequently
lipidated by interaction with peripheral tissue cells. ApoA1 receives cel-
lular cholesterol and phospholipids in a process dependent on ABCA1.
Within the nascent HDL particles, cholesterol is esteriﬁed by lecithin-
cholesteryl acyl transferase (LCAT) associatedwith the growing lipopro-
tein. Using a fatty acyl chain of apoprotein-associated PC, LCAT esteriﬁes
cholesterol in the nascent HDL particles thereby creating a sink for
further cholesterol efﬂux from cells. Patients with mutated ABCA1, as
observed in Tangier disease, have an increased risk of developing
cardiovascular diseases due to a strongly impaired cellular lipid efﬂux
to apoprotein A1 (apoA1), and consequently dramatically reduced plas-
ma HDL levels [254,255]. Cholesterol efﬂux to mature HDL is primarily
mediated by the ABC half transporter ABCG1 and takes place either on
the cell surface or during endocytic recycling of HDL [256]. Targeted
disruption of the gene coding for ABCG1 in mouse results in massive
accumulation of CEs, TAGs and phospholipids in hepatocytes and
macrophages [257]. Recent evidence indicates ABCG1's involvement in
regulating endosomal cholesterol levels, thereby indirectly affecting
1921D. Wüstner, K. Solanko / Biochimica et Biophysica Acta 1848 (2015) 1908–1926the transbilayer sterol distribution in the PM upon fusion of endocytic
vesicles with the cell surface [258]. Expression of ABCA1 and ABCG1 is
under control of the Liver X receptor (LXR) and can be stimulated by
LXR ligands, like 25-hydroxycholesterol [259]. It is currently not
known, which cellular cholesterol pool is dominantly used for ABCA1-
mediated sterol efﬂux. The prevailing hypothesis is that ABCA1 acts in
concert with apoA1 on the cell surface to remove PM cholesterol
being constantly replenished by intracellular sources [254,260]. Other
studies indicate that ABCA1, which follows a complex intracellular
trafﬁcking scheme [255,261,262], mediates lipidation of apoA1 during
its passage through the cell, likely by a retroendocytic pathway [260].
Interestingly, ABCA1-mediated cholesterol efﬂux is not only impaired
in ﬁbroblasts from patients with Tangier disease but also in ﬁbroblasts
from patients suffering from NPC disease and CE storage disorder
[219,263,264]. Reduced conversion of LDL-derived cholesterol into
oxysterols is likely causing the diminished expression of ABCA1 in
these diseases, since oxysterols act as LXR agonists and induce expres-
sion of ABCA1 [224,259]. Importantly, activation of ABCA1 using LXR ag-
onists is sufﬁcient to trigger cholesterol efﬂux to apoA1 in cells lacking
functional NPC1 protein [263], while ABCA1-mediated cholesterol
efﬂux is strictly dependent on the NPC2 protein [234]. These results
demonstrate the importance of the lysosomal cholesterol pool for
ABCA1-dependent cholesterol efﬂux and indicate again different
mechanistic roles for NPC1 and NPC2 in cholesterol mobilization from ly-
sosomes. Interestingly, recent work by Molday and colleagues on
reconstituted ABCA1 shows that this transporter, though being so
central for cellular cholesterol efﬂux, does not bind cholesterol; in fact,
its ATPase activity in phospholipid liposomes actually declines in the pres-
ence of cholesterol [73]. Reconstituted ABCA1 actively translocated ﬂuo-
rescent analogs of PC, SM and PS from the cytoplasmic to the
exoplasmic leaﬂet of membranes [265]. In line with this observation, ac-
tive translocation of PS analogs to the outer leaﬂet of the PM by ABCA1
has been shown in intact cells [266]. This causes altered inner surface
membrane potential and reduced rate of endocytosis [266–268]. Side-
speciﬁc quenchers of DHE and CTL have been used to demonstrate
ABCA1/ABCG1-dependent sterol redistribution from the inner to the
outer leaﬂet of the PM in living cells [269]. Similar experiments on CHO
cells which lack ABCA1 revealed thatmost sterol resides in the inner leaf-
let [137], while sterol ﬂip-ﬂop across membranes is very rapid [79,270,
271]. Together with the absence of cholesterol binding to ABCA1 and
the inhibitory effect on its ATPase activity [73], amechanistic understand-
ing of the enhanced ABCA1-dependent sterol translocation to the
exoplasmic leaﬂet of the PM is lacking. One can hypothesize that active
ﬂopping of PS and other phospholipids ‘pulls’ some cholesterol to the
outer leaf of the PM. In line with this idea are recent observations by
Smith and colleagues, showing that depletion of SM by treating cells
with SMase or by inhibiting sphingolipid synthesis cause PM remodeling
with enhanced PS exposure on the outer leaﬂet and higher cholesterol ef-
ﬂux from cells by ABCA1-dependent and -independent mechanisms
[272]. Importantly, LXR-dependent expression of ABCA1 depends on an-
other ABC transporter, ABCA12, whichwas ﬁrst described tomediate for-
mation of lipid lamellae in the skin. Mutations in ABCA12 cause harlequin
ichthyosis, a devastating skin disease with abnormal lipid granules in
keratinocytes resulting in impairment of the skin barrier function [273].
ABCA12 deﬁciency caused foam cell formation and decreased reverse
cholesterol transport in mice due to a posttranslational impact on
ABCA1 [274]. Thus, as discussed for theNPC proteins,mechanisms under-
lying ABCA1 mediated cholesterol transport are complex and regulated
on several levels. Further discussions of ABC transporters and scavenger
receptors involved in intestinal cholesterol absorption and biliary choles-
terol secretion can be found elsewhere [275,276].
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